1. Home
  2. PRU vs ONC Comparison

PRU vs ONC Comparison

Compare PRU & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PRU

Prudential Financial Inc.

HOLD

Current Price

$98.64

Market Cap

33.9B

Sector

Finance

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$294.16

Market Cap

31.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRU
ONC
Founded
1875
2010
Country
United States
Switzerland
Employees
36824
12000
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.9B
31.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PRU
ONC
Price
$98.64
$294.16
Analyst Decision
Hold
Strong Buy
Analyst Count
15
10
Target Price
$103.71
$385.10
AVG Volume (30 Days)
2.1M
178.0K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
5.81%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$723.76
Revenue Next Year
$3.06
$15.04
P/E Ratio
$10.44
$614.06
Revenue Growth
N/A
N/A
52 Week Low
$91.89
$228.93
52 Week High
$119.76
$385.22

Technical Indicators

Market Signals
Indicator
PRU
ONC
Relative Strength Index (RSI) 54.53 41.83
Support Level $95.76 $283.56
Resistance Level $105.05 $300.00
Average True Range (ATR) 2.07 6.64
MACD 0.08 -2.11
Stochastic Oscillator 58.69 11.89

Price Performance

Historical Comparison
PRU
ONC

About PRU Prudential Financial Inc.

Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2025 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 39% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 11% of its 2025 adjusted earnings. PGIM had around $1.47 trillion in assets under management at the end of fourth-quarter 2025.

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Share on Social Networks: